Evidence map›Paper›PMID 32844325›Full record

ArticleJournal of industrial microbiology & biotechnology2020

Upstream development of Escherichia coli fermentation process with PhoA promoter using design of experiments (DoE).

Frank K Agbogbo, Phil Ramsey, Renija George, Jobin Joy, Shikha Srivastava, Mian Huang, Jesse McCool

Abstract read
In one paragraph

Article in Journal of industrial microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Enhancing3 Biotech · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Frank K AgbogboCytovance Biologics, 800 Research Parkway, Suite 200, Oklahoma City, OK, 73104, USA. fagbogbo@cytovance.com.ORCID http://orcid.org/0000-0002-6550-5929
Phil RamseyPredictum Inc., Austin, TX, USA.
Renija GeorgeCytovance Biologics, 800 Research Parkway, Suite 200, Oklahoma City, OK, 73104, USA.
Jobin JoyCytovance Biologics, 800 Research Parkway, Suite 200, Oklahoma City, OK, 73104, USA.
Shikha SrivastavaCytovance Biologics, 800 Research Parkway, Suite 200, Oklahoma City, OK, 73104, USA.
Mian HuangBioMarin Pharmaceutical Inc., 770 Lindaro Street, San Rafael, CA, 94901, USA.
Jesse McCoolCytovance Biologics, 800 Research Parkway, Suite 200, Oklahoma City, OK, 73104, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this work, a fed-batch fermentation development was performed with recombinant E. coli carrying the PhoA promoter system. The phosphate concentrations tested for this PhoA strain, 2.79 mM to 86.4 mM, were beyond the concentrations previously evaluated for cell growth and product titer. The results from the scouting work was used for design of experiments (DoE) where a range of phosphate levels from 27.1 mM to 86.4 mM was simultaneously evaluated with temperature, pH and DO set points. Definitive screening was used to evaluate these parameters simultaneously and the results indicate that fermentation temperature and phosphate content are the major contributors of product titer. The other factors tested such as pH had a minimal effect and DO had no impact on product titer.

Indexed as

Escherichia coliFermentationPhosphatesPromoter Regions, GeneticPhosphatesDoEE. coliFermentationModelPhoA

Identifiers

PMID32844325
PMCPMC7658055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.